OxLDL causes both epigenetic modification and signaling regulation on the microRNA-29b gene

Novel mechanisms for cardiovascular diseases

Ku Chung Chen, Yi Chu Liao, I. Chung Hsieh, Yung Song Wang, Ching Yu Hu, Suh Hang Hank Juo

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

MicroRNA-29b has been reported to epigenetically regulate proatherogenic genes in response to oxLDL. Since transcription factors and epigenetic regulations are important mechanisms to regulate gene expression, we investigated whether these mechanisms are involved in oxLDL-induced microRNA-29b upregulation. First, we confirmed that microRNA-29b expression was increased in the aorta of mice fed with a high-fat diet, which was consistent with our previous in vitro findings. Next, we found that oxLDL only activated the microRNA-29b-1/microRNA-29a cluster gene on chromosome 7 but not the other distinct microRNA-29b gene located on chromosome 1. Using the promoter reporter assay and chromatin immunoprecipitation, activator protein-1 (AP-1) was shown to bind to the microRNA-29b-1 promoter. We further identified the signaling pathway of LOX-1/Ca 2+/ROS/ERK/c-Fos was involved in oxLDL-mediated microRNA-29b overexpression after treating with the MAPTAM (Ca 2+ chelator), NAC (ROS scavenger), U0126 (ERK inhibitor) and c-Fos (one of the AP-1 proteins) shRNA, respectively. To investigate epigenetic regulations, we found that microRNA-29b promoter contained no CpG islands for DNA methylation. Therefore we investigated whether histone modifications influence microRNA-29b promoter activity. We showed that down-regulation of HDAC1 and the modifications on histone 3 lysine 4 (H3K4) and H3K9 significantly affected microRNA-29b expression. Furthermore, knockdown of c-Fos expression attenuated the effect of oxLDL-induced histone modifications on the microRNA-29b gene expression. Taken together, our data suggest that both transcription factor activation and histone modifications are important regulatory mechanisms of oxLDL-induced atherogenic process. This article is part of a Special Issue entitled OxLDL causes both epigenetic modification and signaling regulation on the microRNA-29b gene: Novel mechanisms for cardiovascular diseases.

Original languageEnglish
Pages (from-to)587-595
Number of pages9
JournalJournal of Molecular and Cellular Cardiology
Volume52
Issue number3
DOIs
Publication statusPublished - Mar 2012
Externally publishedYes

Fingerprint

MicroRNAs
Epigenomics
Cardiovascular Diseases
Histone Code
Genes
Transcription Factor AP-1
oxidized low density lipoprotein
Transcription Factors
Gene Expression
CpG Islands
Chromosomes, Human, Pair 7
Chromatin Immunoprecipitation
Chromosomes, Human, Pair 1
High Fat Diet
DNA Methylation
Chelating Agents
Multigene Family
Small Interfering RNA
Transcriptional Activation
Lysine

Keywords

  • AP-1
  • Atherosclerosis
  • Histone modification
  • MiR-29b
  • OxLDL

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

OxLDL causes both epigenetic modification and signaling regulation on the microRNA-29b gene : Novel mechanisms for cardiovascular diseases. / Chen, Ku Chung; Liao, Yi Chu; Hsieh, I. Chung; Wang, Yung Song; Hu, Ching Yu; Juo, Suh Hang Hank.

In: Journal of Molecular and Cellular Cardiology, Vol. 52, No. 3, 03.2012, p. 587-595.

Research output: Contribution to journalArticle

Chen, Ku Chung ; Liao, Yi Chu ; Hsieh, I. Chung ; Wang, Yung Song ; Hu, Ching Yu ; Juo, Suh Hang Hank. / OxLDL causes both epigenetic modification and signaling regulation on the microRNA-29b gene : Novel mechanisms for cardiovascular diseases. In: Journal of Molecular and Cellular Cardiology. 2012 ; Vol. 52, No. 3. pp. 587-595.
@article{f8fb4adf0cfe404a84f2e3e4597f6a1c,
title = "OxLDL causes both epigenetic modification and signaling regulation on the microRNA-29b gene: Novel mechanisms for cardiovascular diseases",
abstract = "MicroRNA-29b has been reported to epigenetically regulate proatherogenic genes in response to oxLDL. Since transcription factors and epigenetic regulations are important mechanisms to regulate gene expression, we investigated whether these mechanisms are involved in oxLDL-induced microRNA-29b upregulation. First, we confirmed that microRNA-29b expression was increased in the aorta of mice fed with a high-fat diet, which was consistent with our previous in vitro findings. Next, we found that oxLDL only activated the microRNA-29b-1/microRNA-29a cluster gene on chromosome 7 but not the other distinct microRNA-29b gene located on chromosome 1. Using the promoter reporter assay and chromatin immunoprecipitation, activator protein-1 (AP-1) was shown to bind to the microRNA-29b-1 promoter. We further identified the signaling pathway of LOX-1/Ca 2+/ROS/ERK/c-Fos was involved in oxLDL-mediated microRNA-29b overexpression after treating with the MAPTAM (Ca 2+ chelator), NAC (ROS scavenger), U0126 (ERK inhibitor) and c-Fos (one of the AP-1 proteins) shRNA, respectively. To investigate epigenetic regulations, we found that microRNA-29b promoter contained no CpG islands for DNA methylation. Therefore we investigated whether histone modifications influence microRNA-29b promoter activity. We showed that down-regulation of HDAC1 and the modifications on histone 3 lysine 4 (H3K4) and H3K9 significantly affected microRNA-29b expression. Furthermore, knockdown of c-Fos expression attenuated the effect of oxLDL-induced histone modifications on the microRNA-29b gene expression. Taken together, our data suggest that both transcription factor activation and histone modifications are important regulatory mechanisms of oxLDL-induced atherogenic process. This article is part of a Special Issue entitled OxLDL causes both epigenetic modification and signaling regulation on the microRNA-29b gene: Novel mechanisms for cardiovascular diseases.",
keywords = "AP-1, Atherosclerosis, Histone modification, MiR-29b, OxLDL",
author = "Chen, {Ku Chung} and Liao, {Yi Chu} and Hsieh, {I. Chung} and Wang, {Yung Song} and Hu, {Ching Yu} and Juo, {Suh Hang Hank}",
year = "2012",
month = "3",
doi = "10.1016/j.yjmcc.2011.12.005",
language = "English",
volume = "52",
pages = "587--595",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - OxLDL causes both epigenetic modification and signaling regulation on the microRNA-29b gene

T2 - Novel mechanisms for cardiovascular diseases

AU - Chen, Ku Chung

AU - Liao, Yi Chu

AU - Hsieh, I. Chung

AU - Wang, Yung Song

AU - Hu, Ching Yu

AU - Juo, Suh Hang Hank

PY - 2012/3

Y1 - 2012/3

N2 - MicroRNA-29b has been reported to epigenetically regulate proatherogenic genes in response to oxLDL. Since transcription factors and epigenetic regulations are important mechanisms to regulate gene expression, we investigated whether these mechanisms are involved in oxLDL-induced microRNA-29b upregulation. First, we confirmed that microRNA-29b expression was increased in the aorta of mice fed with a high-fat diet, which was consistent with our previous in vitro findings. Next, we found that oxLDL only activated the microRNA-29b-1/microRNA-29a cluster gene on chromosome 7 but not the other distinct microRNA-29b gene located on chromosome 1. Using the promoter reporter assay and chromatin immunoprecipitation, activator protein-1 (AP-1) was shown to bind to the microRNA-29b-1 promoter. We further identified the signaling pathway of LOX-1/Ca 2+/ROS/ERK/c-Fos was involved in oxLDL-mediated microRNA-29b overexpression after treating with the MAPTAM (Ca 2+ chelator), NAC (ROS scavenger), U0126 (ERK inhibitor) and c-Fos (one of the AP-1 proteins) shRNA, respectively. To investigate epigenetic regulations, we found that microRNA-29b promoter contained no CpG islands for DNA methylation. Therefore we investigated whether histone modifications influence microRNA-29b promoter activity. We showed that down-regulation of HDAC1 and the modifications on histone 3 lysine 4 (H3K4) and H3K9 significantly affected microRNA-29b expression. Furthermore, knockdown of c-Fos expression attenuated the effect of oxLDL-induced histone modifications on the microRNA-29b gene expression. Taken together, our data suggest that both transcription factor activation and histone modifications are important regulatory mechanisms of oxLDL-induced atherogenic process. This article is part of a Special Issue entitled OxLDL causes both epigenetic modification and signaling regulation on the microRNA-29b gene: Novel mechanisms for cardiovascular diseases.

AB - MicroRNA-29b has been reported to epigenetically regulate proatherogenic genes in response to oxLDL. Since transcription factors and epigenetic regulations are important mechanisms to regulate gene expression, we investigated whether these mechanisms are involved in oxLDL-induced microRNA-29b upregulation. First, we confirmed that microRNA-29b expression was increased in the aorta of mice fed with a high-fat diet, which was consistent with our previous in vitro findings. Next, we found that oxLDL only activated the microRNA-29b-1/microRNA-29a cluster gene on chromosome 7 but not the other distinct microRNA-29b gene located on chromosome 1. Using the promoter reporter assay and chromatin immunoprecipitation, activator protein-1 (AP-1) was shown to bind to the microRNA-29b-1 promoter. We further identified the signaling pathway of LOX-1/Ca 2+/ROS/ERK/c-Fos was involved in oxLDL-mediated microRNA-29b overexpression after treating with the MAPTAM (Ca 2+ chelator), NAC (ROS scavenger), U0126 (ERK inhibitor) and c-Fos (one of the AP-1 proteins) shRNA, respectively. To investigate epigenetic regulations, we found that microRNA-29b promoter contained no CpG islands for DNA methylation. Therefore we investigated whether histone modifications influence microRNA-29b promoter activity. We showed that down-regulation of HDAC1 and the modifications on histone 3 lysine 4 (H3K4) and H3K9 significantly affected microRNA-29b expression. Furthermore, knockdown of c-Fos expression attenuated the effect of oxLDL-induced histone modifications on the microRNA-29b gene expression. Taken together, our data suggest that both transcription factor activation and histone modifications are important regulatory mechanisms of oxLDL-induced atherogenic process. This article is part of a Special Issue entitled OxLDL causes both epigenetic modification and signaling regulation on the microRNA-29b gene: Novel mechanisms for cardiovascular diseases.

KW - AP-1

KW - Atherosclerosis

KW - Histone modification

KW - MiR-29b

KW - OxLDL

UR - http://www.scopus.com/inward/record.url?scp=84862791919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862791919&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2011.12.005

DO - 10.1016/j.yjmcc.2011.12.005

M3 - Article

VL - 52

SP - 587

EP - 595

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 3

ER -